DOI QR코드

DOI QR Code

Henoch-$Sch{\ddot{o}}nlein$ 자반증에서 항인지질 항체의 임상적 의의

The Clinical Significance of Antiphospholipid Antibodies in Korean Children with Henoch-$Sch{\ddot{o}}nlein$ Purpura

  • 박은정 (연세대학교 의과대학 소아과학교실) ;
  • 백지영 (연세대학교 의과대학 소아과학교실) ;
  • 신재일 (연세대학교 의과대학 소아과학교실) ;
  • 이재승 (연세대학교 의과대학 소아과학교실) ;
  • 김현숙 (연세대학교 의과대학 진단검사의학교실)
  • Park, Eun-Jung (Department of Pediatrics, Yonsei University college of Medicine) ;
  • Baek, Ji-Young (Department of Pediatrics, Yonsei University college of Medicine) ;
  • Shin, Jae-Il (Department of Pediatrics, Yonsei University college of Medicine) ;
  • Lee, Jae-Seung (Department of Pediatrics, Yonsei University college of Medicine) ;
  • Kim, Hyon-Suk (Department of Laboratory Medicine, Yonsei University college of Medicine)
  • 발행 : 2009.10.31

초록

목적 : Henoch-$Sch{\ddot{o}}nlein$ 자반증에서 항인지질 항체에 대한 연구가 외국에서 몇몇 보고되고 있지만 국내에서는 소아 환자를 대상으로 한 연구가 거의 없는 실정이며 또한 항인지질 항체가 양성인 그룹과 음성인 그룹을 비교하여 연구한 논문은 아직 없는 상태이다. 따라서 한국 소아 Henoch-$Sch{\ddot{o}}nlein$ 자반증에서 항인지질 항체가 양성인 환아의 항인지질 항체의 임상적 의의를 알아보고자 본 연구를 시행하였다. 방법 : 2007년 1월부터 2009년 6월까지 신촌 세브란스 병원 소아청소년과에 내원하여 Henoch-$Sch{\ddot{o}}nlein$ 자반증으로 진단받은 62명의 환아를 대상으로 의무기록을 후향적으로 조사하여 분석하였다. 환아의 일반적인 특징으로 성별, 나이, 복통, 관절통과 자반증 등의 임상 증상을 조사하였고, 검사 소견으로는 백혈구수, 혈색소, 혈소판수, 호산구수, C-반응 단백, 혈침 속도, 단백뇨, 대변 잠혈 검사, 혈청 면역 글로불린(IgG, IgA, IgM, IgE), 혈청 보체(C3, C4), 항핵 항체(ANA), 알부민과 항인지질 항체(루프스 항응고인자, 항카디오리핀 항체, 항${\beta}$ 2GPI 항체) 등을 조사하였다. 결과 : 총 62명의 환아중 남녀 각각 31명이었고 평균 연령은 $6.0{\pm}3.1$세(범위: 1-16세)였다. 루프스 항응고인자 양성인 그룹과 음성인 그룹으로 나누어 비교한 결과 복통, 자반증, 관절통, 신염 등의 임상 증세에서는 두 그룹 간에 통계적으로 유의한 차이가 없는 걸로 나타났으나 검사 소견을 비교하였을 때 양성인 그룹에서 C-반응 단백($4.3{\pm}7.2$ mg/dL vs. $1.3{\pm}1.8$ mg/dL, P=0.035), 혈침 속도($37.5{\pm}26.2 mm/hr vs. $25.1{\pm}22.6$ mm/hr, P=0.039), IgM ($148.1{\pm}48.4$ mg/dL vs. $114.9{\pm}41.5$ mg/dL, P=0.024), C3 ($143.1{\pm}21.9$ mg/dL vs. $129.7{\pm}24.5$ mg/dL, P=0.048), C4 ($30.9{\pm}6.3$ mg/dL vs. $24.9{\pm}7.8$ mg/dL, P=0.002)가 통계학적으로 유의하게 높았다. 결론 : Henoch-$Sch{\ddot{o}}nlein$ 자반증에서 루프스 항응고인자는 29%에서 양성 소견을 보였으며 양성인 그룹에서 염증 인자인 C-반응단백, 혈침 속도 그리고 IgM, C3, C4 수치가 유의하게 높게 측정되었다. 이것은 루프스 항응고인자가 Henoch-$Sch{\ddot{o}}nlein$ 자반증에서 질병의 활성과 병인에 어떤 역할을 수행함을 암시한다고 볼 수 있다.

Purpose : We performed this study to evaluate the incidence and clinical significance of antiphospholipid antibodies (aPL Ab) in Korean children with Henoch-$Sch{\ddot{o}}nlein$ purpura (HSP). Methods : The medical records of 62 patients (31 boys and 31 girls) aged $46.0{\pm}3.1$ (1-16) years with a clinical diagnosis of HSP based on the EULAR/PReS criteria were reviewed retrospectively. From the years 2007 to 2009, the sera from children with acute HSP were tested for aPL Ab such as LA, anti-cardiolipin antibody and anti-${\beta}_2$ glycoprotein I antibody. Results : LA was positive in 18 (29%) of the 62 patients with HSP and We divided the patients into the two groups LA positive group (N=18) and LA negative group (N=44). There were no significant differences between the two groups with regard to abdominal pain, arthralgia and renal involvement, but LA positive group had significantly higher C-reactive protein ($4.3{\pm}7.2$ mg/dL vs. $1.3{\pm}1.8$ mg/dL, P=0.035), erythrocyte sedimentation rate ($37.5{\pm}26.2$ mm/hr vs. $25.1{\pm}22.6$ mm/hr, P= 0.039), IgM ($148.1{\pm}48.4$ mg/dL vs. $114.9{\pm}41.5$ mg/dL, P=0.024), C3 ($143.1{\pm}21.9$ mg/dL vs. $129.7{\pm}24.5$ mg/dL, P=0.048) and C4 levels ($30.9{\pm}6.3$ mg/dL vs. $24.9{\pm}7.8$ mg/dL, P=0.002) compared with LA negative group. Conclusion : We found that the incidence of positive aPL Ab tests was relatively higher in Korean children with HSP and the presence of aPL Ab was associated with acute inflammatory process of HSP. These results suggest that the aPL Ab are involved in the pathogenesis of HSP in children.

키워드

참고문헌

  1. Yang YH, Chuang YH, Wang LC, Huang HY, Gershwin ME, Chiang BL. The immunobiology of Henoch-Schonlein purpura. Autoimmun Rev 2008;7:179-84. https://doi.org/10.1016/j.autrev.2007.11.012
  2. Ballinger S. Henoch-Schonlein purpura. Curr Opin Rheumatol 2003;15:591-4. https://doi.org/10.1097/00002281-200309000-00012
  3. Avcin T. Antiphospholipid syndrome in children. Curr Opin Rheumatol 2008;20:595-600. https://doi.org/10.1097/BOR.0b013e3283060a8c
  4. Briones M, Abshire T. Lupus anticoagulants in children. Curr Opin Hematol 2003;10:375-9. https://doi.org/10.1097/00062752-200309000-00009
  5. Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Arch Dis Child 2002;86:132-3. https://doi.org/10.1136/adc.86.2.132
  6. Abend NS, Licht DJ, Spencer CH. Lupus anticoagulant and thrombosis following Henoch-Schonlein purpura. Pediatr Neurol 2007;36:345-7. https://doi.org/10.1016/j.pediatrneurol.2007.01.005
  7. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006;65:936-41. https://doi.org/10.1136/ard.2005.046300
  8. Szer IS. Henoch-Schonlein purpura. Curr Opin Rheumatol 1994;6:25-31. https://doi.org/10.1097/00002281-199401000-00005
  9. Avcin T, Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 2007;9:212-8. https://doi.org/10.1007/s11926-007-0034-x
  10. Levi M. Measuring activated protein C in plasma to assess its role as a critical modulator of coagulation and inflammation. J Thromb Haemost 2003;1:643-4. https://doi.org/10.1046/j.1538-7836.2003.00152.x
  11. Hunt BJ. Pediatric antiphospholipid antibodies and antiphospholipid syndrome. Semin Thromb Hemost 2008;34:274-81. https://doi.org/10.1055/s-0028-1082271
  12. Norden DK, Ostrov BE, Shafritz AB, Von Feldt JM. Vasculitis associated with antiphospholipid syndrome. Semin Arthritis Rheum 1995;24:273-81. https://doi.org/10.1016/S0049-0172(95)80037-9
  13. Salhan M, Ahluwalia J, Singh S, Minz RW. Antiphospholipid antibodies in children with Henoch-Schonlein purpura: a prospective study from North India. Scand J Rheumatol 2007;36:482-4. https://doi.org/10.1080/03009740701339976
  14. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. High titer of serum antiphospholipid antibody levels in adult Henoch-Schonlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum 2008;59:561-7. https://doi.org/10.1002/art.23528
  15. Shin JI, Lee JS, Kim HS. Lupus anticoagulant and IgM anti-phospholipid antibodies in Korean children with Henoch-Schonlein purpura. Scand J Rheumatol 2009;38:73-4. https://doi.org/10.1080/03009740802482469
  16. Watanabe T, Onda H. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol 2001;16:458-9. https://doi.org/10.1007/s004670100569
  17. Mormile R, D'Alterio V, Treccagnoli G, Sorrentino P. Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children? Vaccine 2004;23:567-8. https://doi.org/10.1016/j.vaccine.2004.07.029
  18. Gharavi EE, Chaimovich H, Cucurull E, Celli CM, Tang H, Wilson WA, et al. Induction of antiphospholipid antibodies by immunization with synthetic viral and bacterial peptides. Lupus 1999;8:449-55. https://doi.org/10.1177/096120339900800607
  19. Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, et al. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies. Rheumatology (Oxford) 2008;47:183-7.
  20. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436-44. https://doi.org/10.1002/art.10072
  21. Male C, Foulon D, Hoogendoorn H, Vegh P, Silverman E, David M, et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2005;106:4152-8. https://doi.org/10.1182/blood-2005-05-2048
  22. Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schonlein purpura. Br J Dermatol 2006;155:983-7. https://doi.org/10.1111/j.1365-2133.2006.07457.x
  23. Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL. Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schonlein purpura. Clin Exp Immunol 2000;122:285-90. https://doi.org/10.1046/j.1365-2249.2000.01361.x
  24. Tajima C, Suzuki Y, Mizushima Y, Ichikawa Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J Rheumatol 1998;25:1730-6.
  25. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998;7:15-22. https://doi.org/10.1191/096120398678919688